Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 45-61, March 2006

Endocrine-disrupting chemicals as modulators of sex steroid synthesis

  • Saffron A. Whitehead, PhD (Professor of Reproductive Endocrinology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 208 8725 5360; fax: +44 208 8725 2993.
  • ,
  • Suman Rice, PhD (Post doctorate Yellow)

Department of Basic Medical Sciences, St George's University of London, Cranmer Terrace, London SW17 ORE, UK

Endocrine-disrupting chemicals (EDCs) are typically identified as compounds that can interact with oestrogen or androgen receptors and thus act as agonists or antagonists of endogenous hormones. Growing evidence shows that they may also modulate the activity/expression of steroidogenic enzymes. These are expressed not only in the adrenal glands and gonads but also in many tissues that have the ability to convert circulating precursors into active hormones. In this way, EDCs may impact both on sexual differentiation and development and on hormone-dependent cancers. This review summarizes the evidence for EDCs as modulators of steroidogenic enzymes, identifies the structure/activity relationship in terms of inhibiting specific enzyme activity, questions whether experimental observations can equate with natural in vivo exposure or dietary intake of EDCs, and finally looks at the mechanisms through which these chemicals may disrupt normal steroidogenesis. In summarizing the evidence, the question of whether or not the dietary intake of these endocrine disrupters could pose a threat to human sexual development and health will be addressed.

Keywords: phyto-oestrogens, xeno-oestrogens, aromatase, hydroxysteroid dehydrogenases, steroidogenesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(05)00070-9

doi:10.1016/j.beem.2005.09.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 45-61, March 2006